# Glass House Brands Inc.: overview GLAS · NYSE · CIK 1848731 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/glas.md) · [Financials](/companies/glas/financials.md) · [Filings](/companies/glas/filings.md) · [Insiders](/companies/glas/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [63.2](/filings/0001104659-24-042091.md) | [84.9](/filings/0001104659-24-042091.md) | [161](/filings/0001848731-25-000007.md) | [201](/filings/0001848731-26-000015.md) | [182](/filings/0001848731-26-000015.md) | | Gross margin | % | [25.0%](/filings/0001104659-24-042091.md) | [24.4%](/filings/0001104659-24-042091.md) | [50.3%](/filings/0001848731-25-000007.md) | [48.5%](/filings/0001848731-26-000015.md) | [42.3%](/filings/0001848731-26-000015.md) | | Operating margin | % | [(57.2%)](/filings/0001104659-24-042091.md) | [(66.4%)](/filings/0001104659-24-042091.md) | [(30.8%)](/filings/0001848731-25-000007.md) | [2.9%](/filings/0001848731-26-000015.md) | [(9.1%)](/filings/0001848731-26-000015.md) | | Net margin | % | [(68.2%)](/filings/0001104659-24-042091.md) | [(38.8%)](/filings/0001104659-24-042091.md) | [(61.1%)](/filings/0001848731-25-000007.md) | [0.3%](/filings/0001848731-26-000015.md) | [(16.3%)](/filings/0001848731-26-000015.md) | | Diluted EPS | $ per share | [(1.11)](/filings/0001104659-24-042091.md) | [(0.83)](/filings/0001104659-24-042091.md) | [(1.62)](/filings/0001848731-25-000007.md) | [(0.21)](/filings/0001848731-26-000015.md) | [(0.55)](/filings/0001848731-26-000015.md) | | Free cash flow | $m | [(129)](/filings/0001104659-24-042091.md) | [(68.6)](/filings/0001104659-24-042091.md) | [10.9](/filings/0001848731-25-000007.md) | [18.1](/filings/0001848731-26-000015.md) | [(15.7)](/filings/0001848731-26-000015.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/glas/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Park West Asset Management LLC](/funds/1386928.md) | 2026-06-30 | $67.4m | 5,182,030 | | New +5,182,030 | | [Western Standard LLC](/funds/1517666.md) | 2026-06-30 | $35.0m | 2,728,768 | | New +2,728,768 | | [NOMURA HOLDINGS INC](/funds/1163653.md) | 2026-06-30 | $29.7m | 2,283,439 | | New +2,283,439 | | [CANTOR FITZGERALD, L. P.](/funds/1024896.md) | 2026-06-30 | $16.7m | 1,350,000 | | New +1,350,000 | | [CANTOR FITZGERALD, L. P.](/funds/1024896.md) | 2026-06-30 | $16.7m | 1,350,000 | | New +1,350,000 | | [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $14.9m | 1,145,088 | | New +1,145,088 | | [AdvisorShares Investments LLC](/funds/1425930.md) | 2026-06-30 | $11.1m | 850,000 | | New +850,000 | | [Clear Street Group Inc.](/funds/1881567.md) | 2026-06-30 | $10.2m | 825,000 | | New +825,000 | | [Marex Group Ltd](/funds/1997464.md) | 2026-06-30 | $9.8m | 750,000 | | New +750,000 | | [Hudson Bay Capital Management LP](/funds/1393825.md) | 2026-06-30 | $9.8m | 750,000 | | New +750,000 | ## Recent filings [All 194 filings](/companies/glas/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-26 | 16:39 ET | [6-K](/filings/0001104659-26-118806.md) | Report of a foreign private issuer, period 2026-10-26 | 0001104659-26-118806 | | 2026-10-19 | 13:58 ET | [6-K](/filings/0001848731-26-000033.md) | Report of a foreign private issuer, period 2026-10-19 | 0001848731-26-000033 | | 2026-10-09 | 16:37 ET | [6-K](/filings/0001104659-26-115067.md) | Report of a foreign private issuer, period 2026-10-09 | 0001104659-26-115067 | | 2026-09-29 | 07:35 ET | [6-K](/filings/0001104659-26-111597.md) | Report of a foreign private issuer, period 2026-09-29 | 0001104659-26-111597 | | 2026-09-11 | 16:35 ET | [6-K](/filings/0001104659-26-107092.md) | Report of a foreign private issuer, period 2026-09-11 | 0001104659-26-107092 | | 2026-08-14 | 16:06 ET | [6-K](/filings/0001848731-26-000031.md) | Report of a foreign private issuer, period 2026-06-30 | 0001848731-26-000031 | | 2026-08-13 | 16:10 ET | [6-K](/filings/0001848731-26-000028.md) | Report of a foreign private issuer, period 2026-08-13 | 0001848731-26-000028 | | 2026-07-15 | 08:01 ET | [6-K](/filings/0001104659-26-083735.md) | Report of a foreign private issuer, period 2026-07-15 | 0001104659-26-083735 | | 2026-06-18 | 17:25 ET | [6-K](/filings/0001104659-26-075884.md) | Report of a foreign private issuer, period 2026-06-18 | 0001104659-26-075884 | | 2026-06-17 | 10:39 ET | [6-K](/filings/0001104659-26-074968.md) | Report of a foreign private issuer, period 2026-06-17 | 0001104659-26-074968 | ## Latest annual report [Form 40-F for the fiscal year ended Dec 31, 2025](/filings/0001848731-26-000015.md), filed Mar 24, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1848731 - Tickers: GLAS - Exchange: NYSE - SIC code: 2833 Medicinal Chemicals & Botanical Products - State of incorporation: A1 - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:40 ET. No prices; not investment advice.